ArticleEJHaem2024
Low-dose nivolumab for extranodal natural killer/T-cell lymphoma, nasal type.
Satish Maharaj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEJHaem2024
Satish Maharaj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.